Recombinant Human CDH17, partial (Active)
Cadherin-17 (corresponding to CDH17) is a newly discovered member of the cadherin superfamily. Cadherins act as Ca2+-dependent transmembrane glycoproteins that mediate cell-cell adhesion. To date, there is a growing focus on CDH17 in tumors, particularly gastrointestinal cancers (GICs). Some target identification lies at the heart of GIC treatment, like EGFR, HER-2, PD-1, MET, CTLA4, VEGF, DDR1, LAG3, MUC1, TIGIT, and CLDN18.2. CDH17 offers new insights into immunotherapy for tumors, particularly gastrointestinal cancers.
The aim of BTL Biotechno Labs Pvt. Ltd. is to accelerate scientific discovery by supporting and marketing unique products for the life sciences with technical support. As a trusted channel partner of Cusabio, we provide their compressive range of CDH17 active protein and antibody in India to fully support researchers and pharmaceutical companies in their research on CDH17 in gastrointestinal cancers.
For more details, please follow the link below:
Cusabio | CDH17
